In Utero Enzyme Replacement TherapyPregnant patients with a diagnosed fetal lysosomal storage disease may have the opportunity to receive a promising treatment that could improve their babies’ health after birth.
UCSF and I-SPY 2 Breast Cancer Researchers Develop Newly Redefined Breast Cancer Response SubtypesResearch scientists and statisticians from UC San Francisco have developed improved biomarker classifications as part of their research results in the I-SPY 2 trial for high-risk breast cancer patients.
New Guidance for Reducing Medication-Related Dementia Risk in Patients With Overactive BladderThis consensus paper is designed to update urologists and other healthcare providers who prescribe anticholinergics about the risks of these medications and help guide them on when to use anticholinergics and when it is appropriate to use alternatives.
Abortion Ban May Increase Risk of Death for Pregnant Women with CancerThe repercussions of overturning Roe v. Wade – and the failure of the Supreme Court to provide any guidance on exceptions related to the life and health of the mother – are potentially catastrophic for a subset of women who face a life-threating diagnosis of pregnancy associated cancers (PAC).
Brachytherapy Improves Outcomes for Cervical Cancer PatientsPatients with locally advanced cervical cancer who receive chemoradiation therapy and brachytherapy and complete treatment within eight weeks have a superior overall survival rate compared to those who don’t receive this treatment, according to a UCSF study.
How to Assign Malignancy Risk to Adnexal Masses Based on Imaging FeaturesAdoption of the Ovarian-Adnexal Reporting and Data System (O-RADS) by UCSF radiologists, gynecologists and gynecologic oncologists has reduced ambiguity in ultrasound (US) and MRI reporting of ovarian and adnexal lesions, with enormous potential to improve patient outcomes.
Gynecologic Cancer and Lynch Syndrome: Identifying Genetic Variants Leads to Precision TreatmentGiven the increased risks associated with Lynch syndrome for gynecologic, colon and other cancers, physicians at the UCSF Gynecologic Oncology Center now approach testing, surveillance and treatment based on each patient’s individual genetic risk.
COVID-19 During Pregnancy Associated with Preterm Birth, UCSF-Led Study FindsPregnant people infected with COVID-19 face an increased risk of very preterm birth (VPTB), preterm birth (PTB) or early term birth, according to a large population-based study led by researchers at UC San Francisco.
UCSF MD Link: Web-Based Communication Portal for PhysiciansOur web portal allows referring physicians to securely access their patients’ entire electronic health record, make online referral requests and communicate with our physicians directly and securely.
2019-20 Referral Services GuideUCSF Health is recognized throughout the world for innovative treatments, advanced technology, collaboration among clinicians and scientists, and a highly compassionate team of patient care providers.
Breast OncologyExpert care and transformative research working together to improve both survival and quality of life